Company intelligence / Profile preview

Digestix Bioscience

Bethesda, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Digestix Bioscience is in pre-clinical development of an endoscopic medical device and a co-administered pharmaceutical composition designed to locally prevent recurrence of adenomatous colorectal polyps and other early-stage neoplastic local tumors; no clinical results have been reported publicly yet.

Therapeutic areas: OncologyGastroenterology
Modalities: DeviceSmall molecule
Industry: Biotech

Partnerships

CNBX Pharmaceuticals (intra-group research services agreement whereby CNBX provides research services to Digestix Bioscience for its development programs)

Beyond the preview

Go deeper on Digestix Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Digestix Bioscience.

Explore the full profile